Conversely, KRAS mutations are detected early in pancreatic ductal adenocarcinomas and pancreatic intraepithelial neoplasia (PanIN) mutations in more progressed lesions are definitive precursors to the invasive disease [14]. This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.